⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25221985 | 1.00 | — | — | |
| SCHEMBL9651237 | 0.81 | — | — | |
| SCHEMBL9651230 | 0.81 | — | — | |
| SCHEMBL6686739 | 0.79 | — | — | |
| SCHEMBL19638604 | 0.79 | — | — | |
| SCHEMBL14195896 | 0.79 | — | — | |
| SCHEMBL25009059 | 0.79 | — | — | |
| SCHEMBL24178796 | 0.79 | — | — | |
| SCHEMBL22029812 | 0.79 | — | — | |
| SCHEMBL6675135 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230165970-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2023-06-01 | — | — | US | disclosed |